Suppr超能文献

英国血红蛋白病产前诊断审计:头20年

Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years.

作者信息

Modell B, Petrou M, Layton M, Varnavides L, Slater C, Ward R H, Rodeck C, Nicolaides K, Gibbons S, Fitches A, Old J

机构信息

Department of Obstetrics and Gynaecology, University College London Medical School.

出版信息

BMJ. 1997 Sep 27;315(7111):779-84. doi: 10.1136/bmj.315.7111.779.

Abstract

OBJECTIVES

To audit services for prenatal diagnosis for haemoglobin disorders in the United Kingdom.

DESIGN

Comparison of the annual number of cases recorded in a United Kingdom register of prenatal diagnoses for haemoglobin disorders, with the annual number of pregnancies at risk of these disorders, by ethnic group and regional health authority. The number of pregnancies at risk was estimated using data on ethnic group from the 1991 census and data from the United Kingdom thalassaemia register, which records the number of babies born with thalassaemia.

SETTING

The three national prenatal diagnosis centres for haemoglobin disorders.

SUBJECTS

2068 cases of prenatal diagnosis for haemoglobin disorders in the United Kingdom from 1974 to 1994.

MAIN OUTCOME MEASURES

Utilisation of prenatal diagnosis by risk, ethnic group, and regional health authority. Proportion of referrals in the first trimester and before the birth of any affected child.

RESULTS

National utilisation of prenatal diagnosis for haemoglobin disorders was around 20%. During the past 10 years it has remained steady at about 50% for thalassaemias and risen from 7% to 13% for sickle cell disorders. Utilisation for sickle cell disorders varies regionally from 2% to 20%. Utilisation for thalassaemias varies by ethnic group. It is almost 90% for Cypriots and ranges regionally for British Pakistanis from 0% to over 60%. About 60% of first prenatal diagnoses are done for couples without an affected child. Less than 50% of first referrals are in the first trimester.

CONCLUSIONS

National utilisation of prenatal diagnosis for haemoglobin disorders is far lower than expected, and there are wide regional variations. A high proportion of referrals are still in the second trimester and after the birth of an affected child. The findings point to serious shortcomings in present antenatal screening practice and in local screening policies and to inadequate counselling resources, especially for British Pakistanis.

摘要

目的

审核英国血红蛋白病的产前诊断服务。

设计

按种族和地区卫生当局,比较英国血红蛋白病产前诊断登记册中记录的年度病例数与这些疾病风险妊娠的年度数量。利用1991年人口普查的种族数据和英国地中海贫血登记册的数据估计风险妊娠的数量,该登记册记录了患地中海贫血的婴儿数量。

地点

三个国家血红蛋白病产前诊断中心。

研究对象

1974年至1994年英国2068例血红蛋白病产前诊断病例。

主要观察指标

按风险、种族和地区卫生当局划分的产前诊断利用率。孕早期及任何患病儿童出生前转诊的比例。

结果

全国血红蛋白病产前诊断的利用率约为20%。在过去10年中,地中海贫血的利用率一直稳定在约50%,镰状细胞病的利用率从7%上升到13%。镰状细胞病的利用率在各地区从2%到20%不等。地中海贫血的利用率因种族而异。塞浦路斯人几乎达到90%,英国巴基斯坦人的利用率在各地区从0%到超过60%不等。约60%的首次产前诊断是针对没有患病儿童的夫妇进行的。不到50%的首次转诊发生在孕早期。

结论

全国血红蛋白病产前诊断的利用率远低于预期,且地区差异很大。仍有很大比例的转诊发生在孕中期和患病儿童出生后。研究结果表明目前的产前筛查实践、当地筛查政策存在严重缺陷,咨询资源不足,尤其是针对英国巴基斯坦人。

相似文献

4
Prenatal screening for haemoglobin disorders.血红蛋白病的产前筛查
Prenat Diagn. 1995 Dec;15(13):1275-95. doi: 10.1002/pd.1970151308.
7
Delivering genetic screening to the community.为社区提供基因筛查。
Ann Med. 1997 Dec;29(6):591-9. doi: 10.3109/07853899709007488.

引用本文的文献

2
Changing patterns in the epidemiology of β-thalassemia.β地中海贫血流行病学模式的变化
Eur J Haematol. 2020 Dec;105(6):692-703. doi: 10.1111/ejh.13512. Epub 2020 Sep 21.
4
Responsible implementation of expanded carrier screening.负责开展扩大的携带者筛查。
Eur J Hum Genet. 2016 Jun;24(6):e1-e12. doi: 10.1038/ejhg.2015.271. Epub 2016 Mar 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验